Use of synthetic peptides to identify measles in nucleoprotein T-cell epitopes in vaccinated and naturally infected humans

Virology

Volumn 235, Issue 2, 1997, Pages 386-397

  Hickman, Carole J ^a   Khan, Ali S ^a   Rota, Paul A ^a   Bellini, William J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEASLES VACCINE; NUCLEOPROTEIN; SYNTHETIC PEPTIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; PRIORITY JOURNAL; RETROBULBAR DRUG ADMINISTRATION; T LYMPHOCYTE; VACCINATION;

MEASLES VIRUS;

EID: 0030855916     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8678     Document Type: Article

References (61)

1. Bankamp B., Brinckmann U. G., Reich A., Niewiesk S., ter Meulen V., Liebert U. G. Protection from measles encephalitis of Lewis rats with vaccinia virus recombinants expressing the measles virus nucleocapsid protein. J. Virol. 65:1991;1695-1701.
2. Beauverger P., Buckland R., Wild T. F. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive T lymphocytes in mice: Localization of a common Ld restricted nucleoprotein epitope. J. Gen. Virol. 74:1993;2357-2363.
3. Beauverger P., Chadwick J., Buckland R., Wild T. F. Serotype specific and canine distemper virus cross-reactive H-2k restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein. Virology. 203:1994;172-177.
4. Brodsky F. M. A matrix approach to human class II histocompatibility antigens: Reactions of four monoclonal antibodies with the products of nine haplotypes. Immunogenetics. 19:1984;179-194.
5. Brodsky F. M., Parham P. Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J. Immunol. 128:1982;129-135.
6. Buckland R., Giraudon P., Wild F. Expression of measles virus nucleoprotein inEscherichia coli. J. Gen. Virol. 70:1989;435-441.
7. Burnet F. M. Measles as an index of immunological function. Lancet. 2:1968;610-613.
8. Celis E., Karr R. W., Deitzhold B., Wunner W. H., Koprowski H. Genetic restriction and fine specificity of human T cell clones reactive with rabies virus. J. Immunol. 141:1988;2721-2728.
9. Morbid. Mortal. Wkly. Rep. 4337:1994a;673-676.
10. MMWR. 4334:1994b;627-629.
11. Chaye H., Dawei O., Chong P., Gilla S. Human T- and B-cell epitopes of E1 glycoprotein of rubella virus. J. Clin. Immunol. 13:1993;93-100.
12. Devereaux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:1984;387-395.
13. Faith A., Moreno R., Lathriga R., Roman E., Fernandez M., Brett S., Mitchell D. M., Ivanyi J., Rees A. D. Analysis of human T-cell epitopes in the 19000 MW antigen ofMycobacterium tuberculosis. Immunology. 74:1991;1-7.
14. Flomberg N., Hansen J. A., Klein S., Dupont B. Joint reports: T-cell recognition of HLA class II molecules. Immunobiology of HLA. 1989;Springer-Verlag, New York. p. 443-.
15. Garlie N. K., Eckels D. D. Idiotype-specific autologous T-cell interactions restricted by HLA-DR. Hum. Immunol. 39:1994;69-75.
16. Giles R. C., Nunez G., Hurley C. K., Nunez-Roldan A., Winchester R., Stastny P., Capra J. D. Structural analysis of a human I-A like homologue using a monoclonal antibody that recognizes an MB3-like specificity. J. Exp. Med. 157:1983;1461-1470.
17. Giraudon P., Buckland R., Wild T. F. The immune response to measles virus in mice. T-helper response to the nucleoprotein and mapping of the T-helper epitopes. Virus Res. 22:1991;41-54.
18. Giraudon P., Jacquier M. F., Wild T. F. Antigenic analysis of African measles virus field isolates: Identification and localisation of one conserved and two variable epitope sites on the NP protein. Virus Res. 18:1988;137-152.
19. Good R. A., Zak S. J. Disturbances in gamma globulin synthesis as "experiments of nature" Pediatrics. 18:1956;109-149.
20. Graves M., Griffin D. E., Johnson R. T., Hirsch R. L., Lindo de Doriano I., Roedenbeck S., Vaisberg A. Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections. J. Virol. 49:1984;409-412.
21. Griffin D. E., Ward B. J., Esolen L. M. Pathogenisis of measles virus infection: An hypothesis for altered immune responses. J. Infect. Dis. 170:1994;S24-S31.
22. Hoffman R. W., Takeda Y., Sharp G. C., Lee D. R., Hill D. L., Kaneoka H., Caldwell C. W. Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. J. Immunol. 151:1993;6460-6469.
23. Ilonen J., Makela M. J., Ziola B., Salmi A. A. Cloning of human T cells specific for measles virus hemagglutinin and nucleocapsid. Clin. Exp. Immunol. 81:1990;212-217.
24. Ito Y., Nieda M., Uchigata Y., Nishimura M., Tokunaga K., Kuwata S., Obata F., Tadokoro K., Hirata Y., Omori Y., Juji T. Recognition of human insulin I the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J. Immunol. 151:1993;5770-5776.
25. Jacobson S., Rose J. W., Flerlage M. L., McFarlin D. E., McFarland H. F. Induction of measles virus specific human cytotoxic cells by purified measles virus nucleocapsid and hemagglutinin polypeptides. Viral Immunol. 1:1987/1988;153-162.
26. Kanof M. E. Isolation of T cells using rosetting procedures. Coligan J. E., Kruisbeek A. M., Margulies D. H., Shevach E. M., Strober W. Current protocols in Immunology. 1996;7.2.1-7.2.4 Wiley, New York.
27. Kernahan J., McQuillin J., Craft A. W. Measles in children who have malignant disease. Br. Med. J. 295:1987;15-18.
28. Kilgus J., Jardetzsky T., Gorga J. C., Trzeciak A., Gillessen D., Sinigaglia F. Analysis of the permissive association of a malaria T cell epitope with DR molecules. J. Immunol. 146:1991;307-315.
29. Krause P. J., Cherry J. D., Carney J., Naiditch M. J., O'Connor K. Measles specific lymphocyte reactivity and serum antibody in subjects with different measles histories. Am. J. Dis. Child. 134:1980;567-571.
30. Krugman S. Further-attenuated measles vaccine: Characteristics and use. Rev. Infect. Dis. 5:1983;477-481.
31. Lampson L. A., Levy R. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125:1980;293-298.
32. +. Clin. Exp. Immunol. 81:1990;177-182.
33. Markowitz L. E., Prebld S. R., Fine P. E. M., Orenstein W. A. Duration of live measles vaccine-induced immunity. Pediatr. Infect. Dis. J. 9:1990;101-110.
34. Markowitz L. E., Chandler F. W., Roldan E. O., Saldana M. J., Roach K. C., Hutchins S. S., Preblud S. R., Mitchell C. D., Scott G. B. Fatal pneumonia without rash in a child with AIDS. J. Infect. Dis. 158:1988;480-483.
35. Markowitz L. E., Preblud S. R., Fine P. E. M., Orenstein W. A. Duration of live measles vaccine-induced immunity. Pediatr. Infect. Dis. J. 9:1990;101-110.
36. Mathias R. G., Meekison W. G., Arcand T. A., Schechter M. T. The role of secondary vaccine failure in measles outbreaks. Am. J. Public Health. 79:1989;475-478.
37. McCarthy M., Lovett A., Kerman R. H., Overstreet A., Wolinsky J. S. Immunodominant T cell epitopes of rubella virus structural proteins defined by synthetic peptides. J. Virol. 67:1993;672-681.
38. +. Clin. Exp. Immunol. 102:1995;40-45.
39. Norrby E., Gollmar Y. Appearance and persistence of antibodies against different virus components after regular measles infections. Infect. Immun. 11:1972;231-239.
40. Partidos C. D., Vohra P., Steward M. W. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide. Virology. 215:1996;107-110.
41. Phillips R. E., Rowland-Jones S., Nixon D. F., Gotch F. M., Edwards J. P., Ogunlesi A. O., Elvin J. G., Rothbard J. A., Bangham C. R. M., Rizza C. R., McMichael A. J. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 354:1991;453-459.
42. Plebanski M., Burtles S. S. In vitro primary responses of human T cells to soluble protein antigens. J. Immunol. Methods. 170:1994;15-25.
43. Radka S. F., Scott R. G., Stewart S. J. Molecular complexity of HLA-DQw3: The TA10 determinant is located on a subset of Dqw3 β chains. (1987). Hum. Immunol. 18:1987;287-300.
44. Reece J. C., Geysen H. M., Rodda S. J. Mapping the major human T helper epitopes of tetanus toxin. J. Immunol. 151:1993;6175-6184.
45. Reece J. C., McGregor D. L., Geysen H. M., Rodda S. J. Scanning for T helper epitopes with human PBMC using pools of short synthetic peptides. J. Immunol. Methods. 172:1994;241-254.
46. Rima B. K., Earle J. A. P., Yeo R. P., Herlihy L., Baczko K., ter Meulen V., Carabana J., Caballero M., Celma M. L., Fernandez-Munoz R. Temporal and geographical distribution of measles virus genotypes. J. Gen. Virol. 76:1995;1173-1180.
47. Robbins P. A., Evans E. L., Ding A. H., Warner N. L., Brodsky F. M. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes. Hum. Immunol. 18:1987;301-313.
48. Roche P. W., Feng C. G., Britton W. J. Human T-cell epitopes onMycobacterium tuberculosis. Scand. J. Immunol. 43:1996;662-670.
49. Rose J. W., Bellini W. J., McFarlin D. E., McFarland H. F. Human cellular immune response to measles virus polypeptides. J. Virol. 49:1984;988-991.
50. Rota P. A., Bloom A. E., Vanchiere J. A., Bellini W. J. Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology. 198:1994;724-730.
51. Rota J. S., Heath J. L., Rota P. A., King G. E., Celma M. L., Carabana J., Fernandez-Munoz R., Brown D., Jin L., Bellini W. J. Molecular epidemiology of measles virus: Identification of pathways of transmission and implications for measles elimination. J. Infect. Dis. 173:1996;32-37.
52. Rozenblatt S., Eizenberg O., Ben-Levy R., Bellini W. J. Sequence homology within the morbilliviruses. J. Virol. 53:1985;684-690.
53. Shaw S., Ziegler A., DeMars R. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA deletion mutant cell lines. Hum. Immunol. 12:1985;191-211.
54. Simons J., Kutubuddin M., Chow M. Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J. Virol. 67:1993;1262-1268.
55. Sinigaglia F., Guttinger M., Kilgus J., Doran D. M., Matile H., Etlinger H., Trzeciak A., Gillessen D., Pink J. R. L. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature. 336:1988;778-780.
56. Tamin A., Rota P. A., Wang Z., Heath J., Anderson L. J., Bellini W. J. Antigenic analysis of current wild-type and vaccine strains of measles virus. J. Infect. Dis. 170:1994;795-801.
57. Taylor M. J., Godfrey E., Baczko K., ter Meulen V., Wild T. F., Rima B. K. Identification of several different lineages of measles virus. J. Gen. Virol. 72:1991;83-88.
58. Ward B. J., Boulianne N., Ratnam S., Guiot M. C., Couillard M., De Serres G. Cellular immunity in measles vaccine failure: Demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after vaccination. J. Infect. Dis. 172:1995;1591-1595.
59. Weyland C. M., Goronzy J. J. Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis. J. Clin. Invest. 85:1990;1051-1057.
60. Wiertz E. J. H. J., Delvig A., Donders E. M., Donders L. M., Brugghe H. F., vanUnen L. M. A., Timmermans H. A. M., Achtman M., Hoogerhout P., Poolman J. T. T cell responses to outer membrane proteins ofNeisseria meningitidis. Infect. Immun. 64:1996;298-304.
61. +. J. Immunol. 153:1994;4149-4158.